Dopamine transport function is elevated in cocaine users

Journal of Neurochemistry

Volumn 81, Issue 2, 2002, Pages 292-300

  Mash, Deborah C ^a,c   Pablo, John ^a   Ouyang, Qinjie ^a   Hearn, W Lee ^b   Izenwasse, Sari ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Miami Dade Medical Examiner Department   (United States)

^c Department Neurology ^*  (United States)

Author keywords

Binding; Cocaine; Delirium; Dopamine transporter (DAT); Post mortem; Uptake

Indexed keywords

COCAINE; DOPAMINE; DOPAMINE TRANSPORTER;

ADULT; AGITATION; ANIMAL TISSUE; ARTICLE; BINDING SITE; BRAIN DISEASE; BRAIN FUNCTION; CLINICAL ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; CORPUS STRIATUM; DEATH; DELIRIUM; DISEASE ASSOCIATION; DOPAMINE UPTAKE; DOPAMINERGIC TRANSMISSION; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN TISSUE; LIMBIC CORTEX; MALE; NONHUMAN; PARANOIA; PRIORITY JOURNAL; PROTEIN BINDING; REINFORCEMENT; SYNAPTIC TRANSMISSION; SYNAPTOSOME; WITHDRAWAL SYNDROME;

ADULT; ANIMALS; BINDING, COMPETITIVE; BRAIN; BRAIN CHEMISTRY; CAUDATE NUCLEUS; CHRONIC DISEASE; COCAINE; COCAINE-RELATED DISORDERS; CORPUS STRIATUM; CRYOPRESERVATION; DELIRIUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; PAPIO; POSTMORTEM CHANGES; SYNAPTOSOMES; TIME FACTORS;

ANIMALIA; PAPIO HAMADRYAS;

EID: 0036312970     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2002.00820.x     Document Type: Article

References (56)

1. 3H]WIN35,428 binding in the human brain
2. Neurotransmitter transporters: Recent progress
3. Selective dopamine transporter inhibition by cocaine analogs
4. Plasma homovanillic acid and dopamine transporter during cocaine withdrawal
5. Acute and chronic dopamine dynamics in a nonhuman primate model of recreational cocaine use
6. Structural domains of catecholamine transporter chimeras involved in selective inhibition by antidepressants and psychomotor stimulants
7. Behavioral effects of novel cocaine analogs: A comparison with in vivo receptor binding potency
8. Stimulus generalization from cocaine to analogs with high in vitro affinity for dopamine uptake sites
9. Optimization of freezing, storage, and thawing conditions for the preparation of metabolically active synaptosomes from frozen rat and human brain
10. PET measures of amphetamine-induced release in ventral versus dorsal striatum
11. Emerging pattterns of cocaine use and the epidemic of cocaine overdose deaths in Dade County, Florida
12. Drug interactions with the dopamine transporter in cryopreserved human caudate
13. Molecular characterization of the dopamine transporter
14. Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters
15. 3H]CFT) binds to multiple charge-states of the solubilized dopamine transporter in primate striatum
16. Studies in post-mortem dopamine uptake 1. Kinetic characterization of the synaptosomal dopamine uptake in rat and human brain after post-mortem storage and cryopreservation. Comparison with noradrenaline and serotonin uptake
17. Metabolically active synaptosomes can be prepared from frozen rat and human brain
18. Analysis of cocaine and metabolites in brain using solid phase extraction and full-scanning and GC/ion trap mass spectrometry
19. Molecular alterations in the neostriatum of human cocaine addicts
20. Basic pharmacological mechanism of cocaine
21. 3H]serotonin uptake by cocaine comparison between chopped tissue slices and synaptosomes
22. The cocaine analog WIN 35,428 binds to two sites in fresh rat caudate-putamen: Significance of assay procedures
23. Medications development at the National Institute on Drug Abuse: Focus on cocaine
24. Relations between heterogeneity of dopamine transporter binding and function and the behavioral pharmacology of cocaine
25. Kinetics and block of dopamine uptake in synaptosomes from rat caudate nucleus
26. Studies of selected phenyltropanes at monoamine transporters
27. Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys
28. Dopamine transporter proline mutations influence dopamine uptake, cocaine analog recognition and expression
29. 3H]WIN 35,428 binding sites in human striatum
30. Brain dopamine transporter messenger RNA and binding sites in cocaine users: A postmortem study
31. Striatal dopaminergic abnormalities in human cocaine users
32. Protein measurement with the Folin phenol reagent
33. 11C]WIN-35,428
34. A multisubstrate mechanism of striatal dopamine uptake and its inhibition by cocaine
35. 3H]2β-carbomethoxy-3β-(4-fluorophenyl) tropane
36. 123I]β-CIT SPECT measures of dopamine transporter availability in human cocaine addicts
37. 123I]β-CIT SPECT
38. Cocaine recognition sites on the human dopamine transporter in drug overdose victims
39. 3H]GBR 12935 binding
40. Radiolabeling of dopamine uptake sites in mouse striatum-comparision of bindings-sites for cocaine, mazindol, and GBR 12935
41. Cocaine receptors on dopamine transporters are related to self-administration of cocaine
42. High affinity dopamine reuptake inhibitors as potential cocaine antagonists: A strategy for drug development
43. Fatal excited delirium following cocaine use: Epidemiologic findings provide new evidence for mechanisms of cocaine toxicity
44. Relapse to drug-seeking, neural and molecular mechanisms
45. High-affinity cocaine recognition sites on the copamine transporter are elevated in fatal cocaine overdose victims
46. Altered dopaminergic synaptic markers in cocaine psychosis and sudden death
47. Dopamine transporter mutants, small molecules, and approaches to cocaine antagonist/dopamine transporter disinhibitor development
48. Photoaffinity-labeled ligand binding domains on dopamine transporters identified by peptide mapping
49. 11C]WIN35428 positron emission tomgoraphy studies and direct in vitro determination
50. Overview. Medications development for the treatment of drug abuse
51. Decreased binding of 11-C-cocaine in the brain of cocaine addicts
52. Relationship between subjective effects of cocaine and dopamine transporter occupancy
53. Agonal status affects metabolic activity in nerve endings isolated from postmortem human brain
54. Cocaine-Induced psychosis and sudden death in recreational cocaine users
55. Cocaine-associated agitated delirium and the neuroleptic malignant syndrome
56. Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users